JWM
AGIO icon

JPL Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

JPL Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97K Buy
80
+10
+14% +$303 ﹤0.01% 944
2026
Q1 		$2.37K Buy
+70
New +$1.99K ﹤0.01% 926
2025
Q4 		– Sell
-70
Closed -$2.81K – 141
2025
Q3 		$2.81K Buy
+70
New +$2.63K ﹤0.01% 787

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

JPL Wealth Management's AGIO Position: Q2 2026 in Review

JPL Wealth Management increased its Agios Pharmaceuticals (AGIO) stake by 14% in Q2 2026, buying an estimated $303 and bringing the position to 80 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

JPL Wealth Management first reported a position in AGIO in Q3 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • JPL Wealth Management held 80 shares of Agios Pharmaceuticals worth $2.97K as of Q2 2026.
  • JPL Wealth Management bought 10 Agios Pharmaceuticals shares in Q2 2026, an estimated $303.
  • Agios Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #944 holding.
  • JPL Wealth Management first reported a position in Agios Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.